MARY USEVA: Open Payments
NPI 1629473624 · CORTLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 54 payments from 9 companies in 2025. Trend: 2023 $720 · 2024 $1,235 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $452 |
| Teva Pharmaceuticals USA, Inc. | 15 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $282 |
| E.R. Squibb & Sons, L.L.C. | 6 | $185 |
| Neurocrine BioSciences, Inc. | 2 | $132 |
| Alkermes, Inc. | 5 | $113 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Luye Pharma (USA) Ltd. | 2 | $29 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, COBENFY, UZEDY, INGREZZA, Auvelity, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
